SCHEMBL29407786

SCHEMBL29407786

C=C(C)C(=O)NC1CC(c2c(Br)c3c(N)ncnc3n2C)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.39
▸ LRRK2 Q5S007 7/20 0.36
▸ PRMT5 O14744 2/20 0.34
▸ METTL3 Q86U44 2/20 0.34
▸ WDR77 Q9BQA1 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ FGFR1 P11362 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ FGFR2 P21802 1/20 0.34
▸ FGFR4 P22455 1/20 0.34
▸ FGFR3 P22607 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ JAK2 O60674 3/20 0.33
▸ JAK1 P23458 3/20 0.33
▸ JAK3 P52333 3/20 0.33
▸ RIPK2 O43353 1/20 0.33
▸ RET P07949 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22659128 1.00 DYRK1A (0.39) DYRK1ALRRK2PRMT5METTL3WDR77
SCHEMBL22659126 1.00 DYRK1A (0.39) DYRK1ALRRK2PRMT5METTL3WDR77
SCHEMBL22675823 0.77 METTL3 (0.38) METTL3CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL29407676 0.77 METTL3 (0.38) METTL3CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL22658981 0.77 JAK2 (0.36) JAK2JAK1JAK3RETKDR
SCHEMBL29407695 0.77 JAK2 (0.36) JAK2JAK1JAK3RETKDR
SCHEMBL22658983 0.77 JAK2 (0.36) JAK2JAK1JAK3RETKDR
SCHEMBL22658959 0.74 LRRK2 (0.41) DYRK1ALRRK2JAK2JAK1JAK3
SCHEMBL28700136 0.72 LRRK2 (0.43) DYRK1ALRRK2JAK2JAK1JAK3
SCHEMBL22675907 0.70 FGFR1 (0.55) DYRK1ALRRK2CYP3A4CYP2D6FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874707-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2025-04-25 — — CN disclosed
CN-114126620-B FGFR inhibitors and methods of use thereof 传达治疗有限公司 2024-12-31 — — CN disclosed
EP-3968999-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2022-03-23 — — EP disclosed
CN-114126620-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2022-03-01 — — CN disclosed
Send feedback